These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls. Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805 [TBL] [Abstract][Full Text] [Related]
4. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Jarvik GP; Wijsman EM; Kukull WA; Schellenberg GD; Yu C; Larson EB Neurology; 1995 Jun; 45(6):1092-6. PubMed ID: 7783869 [TBL] [Abstract][Full Text] [Related]
5. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Lehtimäki T; Pirttilä T; Mehta PD; Wisniewski HM; Frey H; Nikkari T Hum Genet; 1995 Jan; 95(1):39-42. PubMed ID: 7814023 [TBL] [Abstract][Full Text] [Related]
7. A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Steffens DC; Plassman BL; Helms MJ; Welsh-Bohmer KA; Saunders AM; Breitner JC Biol Psychiatry; 1997 Apr; 41(8):851-6. PubMed ID: 9099411 [TBL] [Abstract][Full Text] [Related]
8. Serum lipoprotein profile and APOE genotype in Alzheimer's disease. Cagnin A; Zambon A; Zarantonello G; Vianello D; Marchiori M; Mercurio D; Miccichè F; Ermani M; Leon A; Battistin L J Neural Transm Suppl; 2007; (72):175-9. PubMed ID: 17982892 [TBL] [Abstract][Full Text] [Related]
9. The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease. Dupuy AM; Mas E; Ritchie K; Descomps B; Badiou S; Cristol JP; Touchon J Gerontology; 2001; 47(4):213-8. PubMed ID: 11408727 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Kivipelto M; Helkala EL; Laakso MP; Hänninen T; Hallikainen M; Alhainen K; Iivonen S; Mannermaa A; Tuomilehto J; Nissinen A; Soininen H Ann Intern Med; 2002 Aug; 137(3):149-55. PubMed ID: 12160362 [TBL] [Abstract][Full Text] [Related]
11. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Tan ZS; Seshadri S; Beiser A; Wilson PW; Kiel DP; Tocco M; D'Agostino RB; Wolf PA Arch Intern Med; 2003 May; 163(9):1053-7. PubMed ID: 12742802 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians. Panza F; Solfrizzi V; Colacicco AM; Basile AM; D'Introno A; Capurso C; Sabba M; Capurso S; Capurso A Neuroreport; 2003 Mar; 14(4):605-8. PubMed ID: 12657895 [TBL] [Abstract][Full Text] [Related]
13. Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease. Hirono N; Mori E; Yasuda M; Imamura T; Shimomura T; Hashimoto M; Tanimukai S; Kazui H; Yamashita H J Neuropsychiatry Clin Neurosci; 1999; 11(1):66-70. PubMed ID: 9990558 [TBL] [Abstract][Full Text] [Related]
14. Head injury and risk of Alzheimer's disease by apolipoprotein E genotype. O'Meara ES; Kukull WA; Sheppard L; Bowen JD; McCormick WC; Teri L; Pfanschmidt M; Thompson JD; Schellenberg GD; Larson EB Am J Epidemiol; 1997 Sep; 146(5):373-84. PubMed ID: 9290497 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Corder EH; Saunders AM; Risch NJ; Strittmatter WJ; Schmechel DE; Gaskell PC; Rimmler JB; Locke PA; Conneally PM; Schmader KE Nat Genet; 1994 Jun; 7(2):180-4. PubMed ID: 7920638 [TBL] [Abstract][Full Text] [Related]
16. Genotypes with the apolipoprotein epsilon4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men. Stengård JH; Pekkanen J; Ehnholm C; Nissinen A; Sing CF Hum Genet; 1996 May; 97(5):677-84. PubMed ID: 8655152 [TBL] [Abstract][Full Text] [Related]
17. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults. Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154 [TBL] [Abstract][Full Text] [Related]
19. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy. Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191 [TBL] [Abstract][Full Text] [Related]
20. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele. Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]